MBOT Share Price Performance
US$1.45
-1.97 (-57.60%)
Price US$1.45
Share Pricen/a
Microbot Medical Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 23 Fair Values set on narratives written by author
MBOT Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
No trending discussion available.
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Microbot Medical Inc. Key Details
Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
- -0.24
- -185.26%
- -4,722.25%
- 0%
About MBOT
- Founded
- 2010
- Employees
- 43
- CEO
- WebsiteView website
Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body’s vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts
